Entities / Company
MediciNova (United States).
company in La Jolla, United States
- Reports this week
- 1
- Active events
- 0
- Connections
- 12
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Gone quiet
No new reports in 90+ days-
MediciNova is preparing for regulatory discussions regarding its MN-166 compound, which is part of the COMBAT-ALS Phase 2/3 trial, and has received a $22 million grant from the NIH.Some support1 report
-
MediciNova, a company based in the United States, has appointed Yuichi Iwaki as President and CEO, with David H. Crean serving as Chief Business Officer.Some support4 reports
No events began in the chosen period. Widen it, or reset.
History
Events by the month they beganJune 2026
2 events- MediciNova is preparing for regulatory discussions regarding its MN-166 compound, which is part of the COMBAT-ALS Phase 2/3 trial, and has received a $22 million grant from the NIH.
- MediciNova, a company based in the United States, has appointed Yuichi Iwaki as President and CEO, with David H. Crean serving as Chief Business Officer.